Paul Kaiser

AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) today announced new results from the ongoing ROCKET Phase 3 clinical...

#TOP-LINE RESULTS FROM ROCATINLIMAB #PHASE3 IGNITE STUDY IN ADULTS with MODERATE TO SEVERE ATOPIC DERMATITIS prn.to/4hlA38A

No, we not ready for #AI to prescribe medications!
www.medpagetoday.com/special-repo...

YouTube video by Rare Disease Day Rare Disease Day 2025 official video

We are rapidly approaching Rare Disease Month, and this year it's more important than ever to raise awareness. Because rare is many. Rare is strong. Rare is proud. #RareDiseaseDay2025

youtu.be/fIvqxQPjisI?...

#BOOM

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial - Nature Medicine In an ongoing phase 1 trial, the combination of two new immunotherapies targeting CTLA-4 and PD-1 was overall well tolerated and elicited encouraging clinical responses in patients with relapsed/refra...

Want to learn more about botensilimab and balstilimab treatment safety and efficacy in patients with #ColorectalCancer? Check out the phase 1 trial results published in #NatureMedicine last year #GI25 #OncSky #Immunotherapy
www.nature.com/articles/s41...

#GISeries: #Zanidatamab was recently approved based off #HerizonBTC01! We 🗣️ design, findings, sequencing and AEs/management with Dr. Shubham Pant

Full Discussion:
- Oncbrothers.com/zanidatamab-...
- Also on the “Oncology Brothers” podcast

#OncSky #MedSky #gism #GI25

#GI25 @ascocancer.bsky.social
Two trials on the tissue factor⛔️, pamrevlumab (PAM) in #PancreaticCancer, both by Dr. Piccozzi:
1⃣LAPIS, a R-Ph3 trial of chemo +/- PAM for LAPC, Oral Abstract #675
2⃣The Precision Promise trial @pancan.bsky.social of PAM+gem/nab-pac for mPDAC, Oral Abstract # 673

Social Listening in Rare Diseases: A Game-Changer for Patient Advocacy and Pharma Strategy - Digital Intervention Rare diseases often fly under the radar, affecting small patient populations and garnering limited public attention. Yet for those living with these conditions, the challenges are immense—delayed diag...

Discover how it transforms insights into actionable strategies in our latest blog: bit.ly/4h0iZWD

🩺 Smarter campaigns
📊 Key tools
✨ Real-world impact

#SocialListening #MarketingInsights #Healthcare

The Future of Social Listening in 2025: What’s Next? As we step into 2025, social listening is poised to evolve in groundbreaking ways, reshaping how brands engage with their audiences. The confluence of advanced technologies like artificial intelligenc...

Social listening in 2025 will evolve with AI-driven insights, predictive analytics, and ethical practices. From niche communities to visual & voice data, brands must stay ahead to connect authentically. #SocialListening #AI #DigitalMarketing #2025Trends #EthicalTech www.linkedin.com/pulse/future...

Image of Paul Kaiser and digital Intervention logo with fireworks

🎉 Happy New Year from Digital Intervention! 🎉

Here’s to new opportunities, continued growth, and making a difference together!

✨ Wishing you a year filled with health, happiness, and success. Let’s make 2025 extraordinary!

#HappyNewYear #DigitalIntervention #SocialListening #2025

Try Deep Research and our new experimental model in Gemini, your AI assistant Try Deep Research, a new research assistant in Gemini Advanced, and a chat optimized version of Gemini 2.0 Flash Experimental.

Google just released a new feature called Deep Research, part of the Gemini 2.0 release, that helps you do research online. It's like having a personal AI assistant that can find information for you and write a report. #AIInnovation #aihealthcare #digitalintervention
blog.google/products/gem...

Pfizer’s IBRANCE® in Combination with Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients with HR+, HER2+ Metastatic Breast Cancer Pfizer Inc. (NYSE:PFE) and Alliance Foundation Trials, LLC (AFT) today announced results from the Phase 3 PATINA trial demonstrating that the addition

Wow, PATINA shows 15 month improved PFS in 1st line HER-2 when palbociclib is added to ET +HER-2 antibodies in maintenance 1st line setting after chemo induction.

👏

#bcsm
#SABCS24
@sabcs.bsky.social
@oncoalert.bsky.social

www.businesswire.com/news/home/20...

I created a SABCS Breast Thought Leader Starter Pack for anyone new to @bsky.app and following @sabcs.bsky.social

Will try to add all thought leaders as I go!

go.bsky.app/MkqBYa7

And so it begins....#SABC24

Reposting for those just coming into social and #Blusky Welcome to #ASH24 The hashtags work on Bluesky and on that other platform #Xsky

All smart cool people here. You're one of those right? #LOLsky

LOL we've all been there #Catsky

We just need social listening on this platform!!! 💙

That's more than me. I don't even have an account #LOL

Sharing for exposeure #medsky #academicsky #oncsky

Image of #ASH24 and social media icons

6 platforms to engage #ASH24 during the conference.
FACEBOOK - www.facebook.com/AmericanSoci...
INSTAGRAM - www.instagram.com/ash_hematolo...
LINKEDIN - www.linkedin.com/company/amer...
X - x.com/ASH_hematology
YOUTUBE - www.youtube.com/@AmericanSoc...
BLUESKY - @ash-hematology.bsky.social

ASH meeting hashtags

ASH meeting hashtags

The ASH annual meeting starts the end of this week and they have published some helpful #hASHtags and info for those following on #TheSocials
#ASHKY #SocialListening #DigitalIntervention #ASH24 #OncologyEducation

Art for a post about social listening

Discover the power of social listening! Monitor online conversations to uncover trends, track brand sentiment, & understand your audience. It's more than just data—it's actionable insights for smarter strategies. Stay ahead & let your audience guide your next big move! #SocialListening

Social listening with digital Intervention

Maximize congress listening by tracking live discussions, analyzing sentiment, and identifying key influencers. Insight: Post-session buzz often reveals unmet needs and emerging trends. Don’t just listen—turn insights into strategy! #CongressListening #HealthcareInnovation #digitalintervention

Excited for #ASH24! 🔬✨ Major data releases from @bmsnews, @merck, & @AstraZeneca on cutting-edge therapies in hematology. From CAR-T updates to novel T-cell engagers, the future of blood cancer treatment. Dec 7-10 in San Diego. #sociallistening #digitalintervention #oncsky #medsky #Hematology

I heard that last week 😀

Yea its tough when you have millions signing up and only 20 employees. They'll get there

Skkets vs beets image

I'm torn about calling mentions on #Bluesky - #Skeets To much like the other platform. Maybe #Beets 😁

#NewSky for #Bluesky
#Datanerd #alert